Early AFP Response Predicts Tumor Response in Liver Cancer Treatment
Author Information
Author(s): Tian Jiahe, Pan Shida, Wang Yilin, Yu Yingying, Wang Siyu, Shen Yingjuan, Yang Luo, Liu Xiaomeng, Qiu Qin, Luan Junqing, Wang Fusheng, Meng Fanping
Primary Institution: Fifth Medical Center of the PLA General Hospital
Hypothesis
An early alpha-fetoprotein (AFP) response could indicate favorable tumor dynamics in response to therapy.
Conclusion
Early AFP response is a significant predictor of long-term survival in liver cancer patients treated with immune checkpoint inhibitors combined with targeted therapy.
Supporting Evidence
- Patients with an early AFP response had a significantly reduced risk of early tumor progression.
- The median overall survival in the early AFP response group was significantly longer than in the poor response group.
- An early AFP response was associated with improved objective response rates.
- The predictive model showed good accuracy with an AUC of 0.73.
- Early AFP response can help identify high-risk patients for timely treatment adjustments.
- Statistical analysis indicated that early AFP response is an independent protective factor.
- Elevated baseline AFP levels were more common in the early progression group.
Takeaway
If a liver cancer patient shows a quick drop in AFP levels after starting treatment, it means they are likely to do better and live longer.
Methodology
This retrospective study analyzed clinical data from liver cancer patients receiving their first immune checkpoint inhibitor combined with targeted therapy.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the selection of participants.
Limitations
The study is limited by its single-center design and relatively small sample size, which may affect the generalizability of the findings.
Participant Demographics
The average age of participants was 57 years, with 86.8% being male.
Statistical Information
P-Value
p = 0.019
Confidence Interval
95% CI: 0.13–0.84
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website